Mood Effects of Serotonin Agonists
NCT03790358 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2024-01-24
Summary
The purpose of this study is to determine the effects of very low doses of serotonergic agonists on depressed mood in human volunteers.
Conditions
- Healthy
Interventions
- DRUG
-
Lysergic Acid Diethylamide
Drug will be administered in solution form.
Sponsors & Collaborators
-
University of Chicago
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-05-01
- Primary Completion
- 2023-01-27
- Completion
- 2023-01-27
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effects of Nutrients Supplementation in Antidepressant Treated Depressive Disorder Patients
NCT04179006 ·Status: UNKNOWN ·Phase: NA
-
The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry
NCT07074652 ·Status: COMPLETED ·Phase: NA
-
Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
NCT00375843 ·Status: COMPLETED ·Phase: PHASE4
-
Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response
NCT00456430 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252330 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on Escitalopram
NCT00707863 ·Status: COMPLETED ·Phase: PHASE4
-
Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
NCT04923425 ·Status: COMPLETED
-
Depressed Mood and Anhedonia in Healthy Adults
NCT05306093 ·Status: COMPLETED ·Phase: NA
-
LSD Therapy for Persons Suffering From Major Depression
NCT03866252 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
NCT05175430 ·Status: COMPLETED ·Phase: PHASE1
-
A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
NCT04226963 ·Status: COMPLETED
-
The Effects of Escitalopram on Cytokines
NCT01587326 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD
NCT00785434 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
NCT01814085 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
NCT00432614 ·Status: COMPLETED ·Phase: PHASE3
-
Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)
NCT03321136 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dynamic Measures of Neurochemistry in Mood Disorders
NCT00178828 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
NCT04433858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
NCT03864614 ·Status: COMPLETED ·Phase: PHASE3
-
Serotonin and Motor Plasticity
NCT03162185 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252356 ·Status: COMPLETED ·Phase: PHASE3
-
Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
NCT00917059 ·Status: COMPLETED ·Phase: PHASE4
-
Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression
NCT02132286 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Study of Low Dose Psilocybin
NCT05227742 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
NCT04623814 ·Status: COMPLETED ·Phase: PHASE1